VEGFA and gastric cancer: Blocking angiogenesis is a key strategy in GC therapy, including anti-vascular endothelial growth factor (VEGF) monoclonal antibodies, VEGF-binding proteins, and VEGF receptor tyrosine kinase inhibitors.[11] Recent studies have confirmed that albumin-bound paclitaxel analogs can maintain high concentrations in the peritoneal cavity for a long time owing to their high molecular weights.